Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial
February 29, 2024 08:30 ET
|
Autonomix Medical, Inc.
Proof-of-concept (PoC) human clinical trial targeting multi-billion-dollar pancreatic cancer market through transvascular RF ablation Agreements represent final steps needed in order to commence...